Content
02/20/2025
Vancouver Canada
Variational AI
completed $5.5 million Seed Round funding. Investors include
Nimbus Synergies (lead), Merck Global Health Innovation Fund, Quimby Investments, Threshold Impact, Flying Fish Partners, A&E Investment.
About
Variational AI has developed Enki, the biopharma industry's first commercially-available foundation model for small molecules. Enki is based on a novel generative AI framework invented by Variational AI that has delivered novel and selective leads to multiple biopharma partners and customers.
Startup
Sector:
AI
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
